Thrivent Financial for Lutherans Cuts Position in Proto Labs, Inc. (NYSE:PRLB)

Thrivent Financial for Lutherans decreased its holdings in Proto Labs, Inc. (NYSE:PRLB – Get Rating) by 2.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 27,815 shares of the industrial products company’s stock after selling 615 shares during the period. Thrivent Financial for Lutherans owned approximately 0.10% of Proto Labs worth $710,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of PRLB. Inspire Investing LLC raised its stake in shares of Proto Labs by 27.9% during the third quarter. Inspire Investing LLC now owns 5,694 shares of the industrial products company’s stock valued at $207,000 after purchasing an additional 1,241 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Proto Labs by 2,422.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 20,864 shares of the industrial products company’s stock valued at $533,000 after purchasing an additional 20,037 shares during the period. Duality Advisers LP purchased a new stake in shares of Proto Labs during the fourth quarter valued at approximately $434,000. Caxton Associates LP raised its stake in shares of Proto Labs by 4.2% during the third quarter. Caxton Associates LP now owns 12,895 shares of the industrial products company’s stock valued at $470,000 after purchasing an additional 523 shares during the period. Finally, Barclays PLC raised its stake in shares of Proto Labs by 26.3% during the third quarter. Barclays PLC now owns 20,752 shares of the industrial products company’s stock valued at $756,000 after purchasing an additional 4,324 shares during the period. Hedge funds and other institutional investors own 88.41% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRLB. TheStreet lowered shares of Proto Labs from a “c-” rating to a “d” rating in a research note on Friday, February 10th. Craig Hallum lifted their price target on shares of Proto Labs from $20.00 to $25.00 and gave the stock a “sell” rating in a research note on Monday, February 13th. Lake Street Capital lifted their price target on shares of Proto Labs from $37.50 to $40.00 in a research note on Monday, February 13th. StockNews.com began coverage on shares of Proto Labs in a research note on Thursday, May 18th. They issued a “buy” rating for the company. Finally, Benchmark upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research note on Monday, February 13th. One equities research analyst has rated the stock with a sell rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $36.67.

Proto Labs Price Performance

Proto Labs stock opened at $31.97 on Thursday. The company has a market cap of $837.61 million, a PE ratio of -8.18 and a beta of 1.19. The company has a fifty day moving average price of $30.84 and a two-hundred day moving average price of $29.08. Proto Labs, Inc. has a 12 month low of $22.04 and a 12 month high of $53.00.

Proto Labs Company Profile

(Get Rating)

Proto Labs, Inc engages in the manufacture of custom prototypes and production parts. It offers 3D printing, CNC machining, and injection molding services. The company was founded by Lawrence J. Lukis and Gregg Bloom on May 5, 1999 and is headquartered in Maple Plain, MN.